 |
MorphoSys AG
MOR
|
1.75 |
- |
2.43 % |
$ 254 M |
Germany |
 |
Assembly Biosciences
ASMB
|
4.27 |
$ 30.08 |
5.69 % |
$ 337 M |
USA |
 |
Ascendis Pharma A/S
ASND
|
947 |
$ 223.99 |
0.95 % |
$ 5 B |
Danmark |
 |
Autolus Therapeutics plc
AUTL
|
1.37 K |
$ 1.41 |
2.55 % |
$ 360 M |
Britain |
 |
Axsome Therapeutics
AXSM
|
13.6 |
$ 158.23 |
0.83 % |
$ 7.87 B |
USA |
 |
I-Mab
IMAB
|
94.1 |
- |
- |
$ 866 M |
China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 |
- |
- |
$ 40.3 B |
USA |
 |
Genfit SA
GNFT
|
1.96 K |
- |
2.54 % |
$ 160 B |
France |
 |
Gilead Sciences
GILD
|
6.23 |
$ 138.83 |
1.18 % |
$ 173 B |
USA |
 |
Galmed Pharmaceuticals Ltd.
GLMD
|
73.3 |
$ 0.58 |
-3.33 % |
$ 540 K |
Israel |
 |
Midatech Pharma plc
MTP
|
137 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
65.5 |
- |
- |
$ 26.5 M |
USA |
 |
AgeX Therapeutics
AGE
|
0.099 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
Acorda Therapeutics
ACOR
|
0.142 |
- |
-24.86 % |
$ 820 K |
USA |
 |
Albireo Pharma
ALBO
|
13.3 |
- |
-0.23 % |
$ 916 M |
USA |
 |
Acasti Pharma
ACST
|
0.203 |
- |
4.01 % |
$ 150 M |
Canada |
 |
Институт стволовых клеток человека
ISKJ
|
2.61 |
- |
- |
- |
Russia |
 |
Grifols, S.A.
GRFS
|
1.71 |
$ 7.75 |
2.24 % |
$ 6.83 B |
Spain |
 |
Adverum Biotechnologies
ADVM
|
76.4 |
- |
- |
$ 86.2 M |
USA |
 |
Acer Therapeutics
ACER
|
25.8 |
- |
2.71 % |
$ 14 M |
USA |
 |
Advaxis
ADXS
|
144 |
- |
-9.65 % |
$ 45.9 M |
USA |
 |
Compugen Ltd.
CGEN
|
49.8 |
$ 2.14 |
2.39 % |
$ 200 M |
Israel |
 |
Ayala Pharmaceuticals
AYLA
|
11.2 |
- |
- |
$ 7.46 M |
Israel |
 |
AbCellera Biologics
ABCL
|
12.8 |
$ 3.45 |
1.47 % |
$ 1.03 B |
Canada |
 |
BioDelivery Sciences International
BDSI
|
1.85 |
- |
-4.8 % |
$ 255 M |
USA |
 |
BeiGene, Ltd.
BGNE
|
66.4 |
- |
0.49 % |
$ 251 B |
Cayman-islands |
 |
Calithera Biosciences
CALA
|
98.5 |
- |
-10.95 % |
$ 876 K |
USA |
 |
Harmony Biosciences Holdings
HRMY
|
1.85 |
$ 28.15 |
1.55 % |
$ 1.62 B |
USA |
 |
Cara Therapeutics
CARA
|
2.58 |
- |
-3.03 % |
$ 260 M |
USA |
 |
Heron Therapeutics
HRTX
|
1.28 |
$ 0.8 |
3.3 % |
$ 133 M |
USA |
 |
ChemoCentryx
CCXI
|
0.0564 |
- |
- |
$ 3.74 B |
USA |
 |
Coherus BioSciences
CHRS
|
5.36 |
$ 1.57 |
2.96 % |
$ 184 M |
USA |
 |
Checkpoint Therapeutics
CKPT
|
3.91 K |
- |
- |
$ 169 M |
USA |
 |
Clovis Oncology
CLVS
|
1.55 |
- |
-7.23 % |
$ 13 M |
USA |
 |
Aeglea BioTherapeutics
AGLE
|
489 |
- |
- |
$ 1.01 B |
USA |
 |
CureVac N.V.
CVAC
|
281 |
- |
- |
$ 867 M |
Germany |
 |
Incyte Corporation
INCY
|
3.79 |
$ 92.2 |
1.56 % |
$ 18 B |
USA |
 |
InMed Pharmaceuticals
INM
|
0.414 |
$ 0.79 |
-3.39 % |
$ 1.93 M |
Canada |
 |
INmune Bio
INMB
|
1.36 K |
$ 1.17 |
- |
$ 21 M |
USA |
 |
Arbutus Biopharma Corporation
ABUS
|
24.5 |
$ 4.51 |
6.37 % |
$ 748 M |
Canada |